Luc Paquet
Chief Executive Officer at Univalor, Inc.
Luc Paquet active positions
Companies | Position | Start | End |
---|---|---|---|
Univalor, Inc.
Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Director/Board Member | 2019-07-14 | - |
Chief Executive Officer | 2019-07-14 | - | |
President | 2019-07-14 | - | |
Immune Biosolutions, Inc.
Immune Biosolutions, Inc. BiotechnologyHealth Technology Immune Biosolutions, Inc. develops polyclonal, recombinant chicken antibodies, diagnostic tools, nutraceuticals and antibody based drugs to explore and resolve health issues. The firm’s products include light speed, sunrise, sunshine-in-a-box, eclipse blocking reagents and aurora detection reagents. The company was founded by Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée in 2012 and is headquartered in Sherbrooke, Canada. | Chief Executive Officer | 2021-11-01 | - |
Corporate Officer/Principal | - | 2021-11-01 |
Career history of Luc Paquet
Former positions of Luc Paquet
Companies | Position | Start | End |
---|---|---|---|
QUANTUM EMOTION CORP. | Director/Board Member | 2016-11-22 | 2021-08-08 |
Independent Dir/Board Member | 2016-11-22 | 2021-08-08 | |
Corporate Secretary | 2020-11-18 | 2021-08-08 | |
TransferTech Sherbrooke
TransferTech Sherbrooke Miscellaneous Commercial ServicesCommercial Services TransferTech Sherbrooke manages research intellectual property. It provides protection, exploitation and valorization of research results. The firm also applies valuation strategies to commercialize technologies, either as licenses or spin-off businesses. The company was founded in January 2007 and is headquartered in Sherbrooke, Canada. | Chief Executive Officer | 2013-07-31 | 2017-12-31 |
President | 2013-07-31 | 2017-12-31 | |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Corporate Officer/Principal | 2013-03-31 | 2013-06-30 |
University of Sherbrooke | Corporate Officer/Principal | 2010-08-31 | 2013-02-28 |
Institut de Pharmacologie et de Biologie Structurale | Director/Board Member | 2006-12-31 | 2012-12-31 |
Training of Luc Paquet
University of Sherbrooke | Undergraduate Degree |
University of Montréal | Doctorate Degree |
Statistics
International
Canada | 8 |
France | 2 |
Operational
Chief Executive Officer | 3 |
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Sectoral
Commercial Services | 4 |
Consumer Services | 4 |
Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
QUANTUM EMOTION CORP. | Electronic Technology |
Private companies | 4 |
---|---|
TransferTech Sherbrooke
TransferTech Sherbrooke Miscellaneous Commercial ServicesCommercial Services TransferTech Sherbrooke manages research intellectual property. It provides protection, exploitation and valorization of research results. The firm also applies valuation strategies to commercialize technologies, either as licenses or spin-off businesses. The company was founded in January 2007 and is headquartered in Sherbrooke, Canada. | Commercial Services |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Commercial Services |
Univalor, Inc.
Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Commercial Services |
Immune Biosolutions, Inc.
Immune Biosolutions, Inc. BiotechnologyHealth Technology Immune Biosolutions, Inc. develops polyclonal, recombinant chicken antibodies, diagnostic tools, nutraceuticals and antibody based drugs to explore and resolve health issues. The firm’s products include light speed, sunrise, sunshine-in-a-box, eclipse blocking reagents and aurora detection reagents. The company was founded by Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée in 2012 and is headquartered in Sherbrooke, Canada. | Health Technology |
- Stock Market
- Insiders
- Luc Paquet
- Experience